Bicipital Tenosynovitis

Bicipital tenosynovitis is a clinical condition characterized by inflammation of the biceps brachii tendon and its surrounding synovial sheath as it courses through the intertubercular (bicipital) groove of the proximal humerus. This condition is most commonly recognized in dogs, particularly in active, working, or athletic breeds, and can be a significant cause of forelimb lameness. The biceps brachii tendon originates from the supraglenoid tubercle of the scapula, passes over the cranial aspect of the shoulder joint, and descends through the intertubercular groove, where it is enveloped by a synovial sheath that communicates with the shoulder joint cavity. Inflammation of this tendon and sheath can arise from acute trauma, chronic overuse, or degenerative changes, leading to pain, lameness, and potential tendon rupture. The condition may be classified as primary (idiopathic) or secondary to underlying shoulder pathology such as osteochondritis dissecans (OCD), medial shoulder instability, or trauma. Surgical management is indicated when conservative therapy fails, and may involve tenodesis of the biceps tendon, arthroscopic debridement, or in severe cases, tenotomy. Accurate diagnosis and appropriate surgical intervention are critical for restoring function and alleviating pain.

The etiology of bicipital tenosynovitis is multifactorial. Primary causes include acute traumatic injuries such as direct blows to the shoulder region, excessive strain during high-impact activities (e.g., agility, flyball, hunting), or repetitive microtrauma from overuse. Chronic overuse is particularly common in working and athletic dogs, leading to degenerative tendinopathy. Secondary causes are associated with concurrent shoulder pathologies, including osteochondritis dissecans (OCD) of the humeral head, which can cause mechanical irritation of the biceps tendon, and medial shoulder instability, which alters the biomechanics of the shoulder joint and increases stress on the biceps tendon. Infectious causes, although rare, may result from penetrating wounds or iatrogenic contamination during intra-articular injections. Immune-mediated inflammatory conditions, such as immune-mediated polyarthritis, can also involve the bicipital tendon sheath. Additionally, congenital or developmental abnormalities, such as a shallow intertubercular groove, may predispose to tendon instability and subsequent inflammation. Neoplastic conditions, such as synovial cell sarcoma, are extremely rare but can mimic bicipital tenosynovitis. The underlying cellular mechanisms involve inflammatory cell infiltration, cytokine release, and degenerative changes in the tendon matrix, leading to pain and dysfunction.

Bicipital tenosynovitis is primarily a disease of dogs, with a higher incidence in medium to large breed, active, and working dogs. Breeds commonly affected include Rottweilers, Labrador Retrievers, Golden Retrievers, German Shepherd Dogs, and mixed-breed dogs engaged in athletic activities. There is no strong sex predilection, although some studies suggest a slight male predominance. The condition typically affects middle-aged to older dogs, with a mean age of onset around 5 to 7 years, but can occur in younger dogs with acute trauma. Working dogs, such as police, military, and search-and-rescue dogs, are at increased risk due to repetitive high-impact activities. The exact incidence is unknown, but it is considered a common cause of forelimb lameness in active dogs. Feline bicipital tenosynovitis is extremely rare and is usually associated with trauma or severe degenerative joint disease. Breed-specific anatomical variations, such as a shallow intertubercular groove, may increase susceptibility. Overall, the condition is more prevalent in dogs that engage in strenuous exercise, particularly those involving jumping, running, and turning.

The pathophysiology of bicipital tenosynovitis involves a cascade of inflammatory and degenerative processes within the biceps brachii tendon and its synovial sheath. Initially, acute trauma or repetitive microtrauma leads to microtears in the tendon fibers, disrupting the collagen matrix and causing local hemorrhage and edema. This triggers an acute inflammatory response characterized by vasodilation, increased vascular permeability, and infiltration of neutrophils and macrophages. Inflammatory mediators, such as prostaglandins, cytokines (e.g., IL-1, TNF-α), and matrix metalloproteinases, are released, leading to further tissue degradation and pain. If the inciting cause persists, the condition progresses to a chronic stage with fibroblastic proliferation, fibrosis, and tendinopathy. The tendon becomes thickened, fibrotic, and may develop calcific deposits. Chronic inflammation can also lead to adhesions between the tendon and its sheath, restricting normal gliding motion. In severe cases, the tendon may undergo partial or complete rupture, often at its origin from the supraglenoid tubercle. The synovial sheath becomes thickened and may produce excessive synovial fluid, contributing to joint effusion. The biomechanical consequence is altered shoulder joint kinematics, leading to secondary muscle atrophy, joint stiffness, and progressive lameness. The pain is mediated by nociceptors within the tendon and synovium, and is exacerbated by shoulder extension and flexion, which place tension on the inflamed tendon.

Predisposing factors for bicipital tenosynovitis can be intrinsic or extrinsic. Intrinsic factors include conformational abnormalities such as a shallow intertubercular groove, which may allow the biceps tendon to subluxate or luxate, causing chronic irritation. Genetic predisposition may play a role in certain breeds, although specific genes have not been identified. Age-related degenerative changes, such as tendinopathy and reduced tendon elasticity, increase susceptibility in older dogs. Obesity and poor physical conditioning can place excessive stress on the shoulder joint and tendon. Extrinsic factors include high-impact activities such as agility, flyball, dock diving, and hunting, which involve repetitive jumping, running, and sharp turns. Trauma from accidents, such as falls or collisions, can cause acute injury. Improper training techniques, inadequate warm-up, and overtraining can contribute to overuse injuries. Previous shoulder surgery or intra-articular injections may predispose to iatrogenic inflammation. Concurrent orthopedic conditions, such as medial shoulder instability or OCD, can alter joint biomechanics and increase stress on the biceps tendon. Environmental factors, such as slippery flooring, may also contribute to abnormal stress on the shoulder.

Clinical signs of bicipital tenosynovitis typically include a gradual onset of forelimb lameness, which may be intermittent initially and worsen with exercise. The lameness is often exacerbated by activities that require shoulder extension and flexion, such as running, jumping, and climbing stairs. Affected dogs may show a shortened stride and may carry the affected limb when standing. Pain is elicited on palpation of the cranial aspect of the shoulder, particularly over the intertubercular groove. Direct pressure on the biceps tendon during palpation, or during extension of the shoulder joint with the elbow flexed, reproduces pain. In chronic cases, muscle atrophy of the supraspinatus, infraspinatus, and biceps muscles may be evident. There may be a positive 'biceps stretch test,' where extension of the shoulder joint with the elbow flexed causes pain. Joint effusion may be palpable in the shoulder joint. In cases of tendon rupture, there may be a sudden onset of severe lameness, and the biceps muscle may appear bunched up due to retraction. Systemic signs such as fever are uncommon unless there is an infectious component. The lameness may be graded on a scale of 0 to 5, with grade 0 being no lameness and grade 5 being non-weight-bearing. Most dogs present with grade 2 to 3 lameness.

Differential diagnoses for bicipital tenosynovitis include: 1) Osteochondritis dissecans (OCD) of the humeral head: This condition typically affects young, large-breed dogs and presents with shoulder pain and lameness. Radiographs may show a subchondral bone defect in the caudocentral aspect of the humeral head. Arthroscopy is diagnostic. 2) Medial shoulder instability: This is characterized by lameness and pain on abduction of the shoulder joint. Stress radiographs or arthroscopy can confirm the diagnosis. 3) Supraspinatus tendinopathy: Inflammation of the supraspinatus tendon can cause similar lameness and pain on palpation of the shoulder. Ultrasound or MRI can differentiate. 4) Infraspinatus contracture: This condition causes a characteristic gait abnormality with the limb held in abduction and external rotation. Palpation reveals a taut infraspinatus tendon. 5) Shoulder joint luxation: Traumatic luxation causes severe lameness and deformity, with radiographs showing the humeral head displaced. 6) Septic arthritis: This presents with acute severe lameness, joint swelling, fever, and systemic signs. Joint aspiration reveals septic inflammation. 7) Immune-mediated polyarthritis: This can cause polyarthropathy with shifting leg lameness, and joint fluid analysis shows non-septic inflammation. 8) Fracture of the supraglenoid tubercle: This is an avulsion fracture that can occur with trauma, causing pain and lameness. Radiographs are diagnostic. 9) Bicipital tendon rupture: This is a severe form of bicipital tenosynovitis where the tendon is completely torn, leading to a bunched-up biceps muscle and severe lameness. 10) Neoplasia: Synovial cell sarcoma or other tumors of the shoulder region can cause lameness and pain, with imaging and biopsy needed for diagnosis.

The diagnostic algorithm for bicipital tenosynovitis begins with a thorough history and physical examination, including a complete orthopedic and neurological examination. The presence of forelimb lameness, pain on shoulder palpation, and a positive biceps stretch test raises suspicion. The next step is sedation or general anesthesia for radiography of the shoulder joint. Standard mediolateral and craniocaudal radiographs may reveal calcification of the biceps tendon, osteophyte formation on the supraglenoid tubercle or intertubercular groove, or evidence of concurrent OCD. However, radiographs are often normal in early cases. If radiographs are inconclusive, advanced imaging such as ultrasonography is recommended. Ultrasound can assess the biceps tendon for thickening, hypoechoic areas, calcification, and fluid accumulation within the tendon sheath. It can also evaluate the intertubercular groove for irregularities. Magnetic resonance imaging (MRI) provides the most detailed soft tissue evaluation, showing tendon degeneration, inflammation, and partial tears. Computed tomography (CT) is useful for evaluating bony changes, such as osteophytes or a shallow groove. Arthroscopy is the gold standard for diagnosis, allowing direct visualization of the tendon and sheath, and can be used for therapeutic intervention. Synovial fluid analysis may be performed to rule out septic or immune-mediated arthritis. The diagnostic algorithm should progress from non-invasive to invasive modalities, with arthroscopy reserved for cases where conservative management has failed or when a definitive diagnosis is needed.

Laboratory findings in bicipital tenosynovitis are typically non-specific. Complete blood count (CBC) and serum biochemistry are usually within normal limits unless there is an underlying systemic disease. In cases of septic arthritis, there may be leukocytosis and a left shift. Synovial fluid analysis is crucial in differentiating inflammatory from non-inflammatory conditions. In bicipital tenosynovitis, synovial fluid from the shoulder joint may show mild to moderate inflammation, with an increased white blood cell count (typically 2,000 to 10,000 cells/µL) and a predominance of mononuclear cells. The mucin clot quality is usually good to fair. In septic arthritis, the fluid is turbid, with a high white blood cell count (>50,000 cells/µL) and a predominance of neutrophils, and bacterial culture may be positive. In immune-mediated arthritis, the fluid is non-septic but inflammatory, with a high percentage of neutrophils. Coagulation panel (PT/aPTT) is not routinely indicated unless surgery is planned and there is a history of bleeding disorders. Inflammatory biomarkers such as C-reactive protein (CRP) and serum amyloid A (SAA) may be elevated in inflammatory conditions but are not specific. Preoperative laboratory evaluation, including CBC, biochemistry, urinalysis, and coagulation profile, is recommended to assess surgical risk.

Imaging plays a pivotal role in the diagnosis of bicipital tenosynovitis. Radiography: Standard mediolateral and craniocaudal radiographs of the shoulder are the initial imaging modality. Findings may include calcification of the biceps tendon within the intertubercular groove, osteophyte formation on the supraglenoid tubercle or the margins of the groove, and evidence of concurrent OCD (subchondral bone defect). In chronic cases, there may be periarticular new bone formation. However, radiographs are often normal in early disease. Ultrasonography: This is a highly sensitive modality for evaluating the biceps tendon and sheath. The tendon is assessed for changes in echogenicity, thickness, and the presence of calcific deposits. The synovial sheath may appear thickened with anechoic fluid accumulation. Dynamic ultrasound during shoulder flexion and extension can assess tendon gliding and detect adhesions. Computed Tomography (CT): CT provides excellent bony detail and can identify subtle changes in the intertubercular groove, such as osteophytes or a shallow groove. It is also useful for evaluating the supraglenoid tubercle. Magnetic Resonance Imaging (MRI): MRI is the gold standard for soft tissue evaluation. It can reveal tendon thickening, intratendinous signal changes (indicative of degeneration or partial tears), and inflammation of the synovial sheath. MRI is particularly useful in diagnosing partial tears that may not be visible on ultrasound. Arthroscopy: This is both diagnostic and therapeutic. Direct visualization allows assessment of the tendon's appearance, including fraying, fibrillation, or rupture, and evaluation of the synovial membrane. Arthroscopy can also identify concurrent intra-articular pathology such as OCD or medial shoulder instability. Fluoroscopy: This is used during arthroscopic procedures to guide instrument placement.

Cytology and histopathology are important in the diagnosis and management of bicipital tenosynovitis. Synovial fluid cytology: Joint aspiration from the shoulder joint may be performed. In bicipital tenosynovitis, the fluid is typically clear to slightly turbid, with good viscosity. The white blood cell count is mildly elevated (2,000-10,000 cells/µL) with a predominance of mononuclear cells (lymphocytes and macrophages). In chronic cases, there may be evidence of cartilage debris. In septic arthritis, the fluid is purulent with a high neutrophil count and bacteria may be seen. Histopathology: If surgical intervention is performed, tissue samples from the biceps tendon and synovial membrane may be submitted for histopathology. Findings typically include chronic inflammation with lymphocytic and plasmacytic infiltration, fibrosis, and degenerative changes in the tendon matrix. In cases of calcific tendinopathy, there may be areas of mineralization. Special stains such as Masson's trichrome can highlight collagen degeneration. In rare cases of neoplasia, histopathology is diagnostic. Surgical biopsy may be indicated if there is suspicion of infection or neoplasia. Histopathology can also help differentiate bicipital tenosynovitis from other conditions such as immune-mediated arthritis, which shows a different inflammatory pattern.

Treatment of bicipital tenosynovitis can be medical or surgical. Medical management is the first line and includes rest, non-steroidal anti-inflammatory drugs (NSAIDs), and physical therapy. NSAIDs such as carprofen (2.2 mg/kg PO q12h) or meloxicam (0.1 mg/kg PO q24h) are commonly used for 2-4 weeks. Strict rest for 4-6 weeks is recommended, followed by a gradual return to activity. Physical therapy, including therapeutic ultrasound, laser therapy, and controlled exercise, may be beneficial. Intra-articular injections of corticosteroids (e.g., methylprednisolone acetate, 10-20 mg per joint) can be used, but repeated injections are discouraged due to potential tendon damage. If medical management fails after 6-8 weeks, surgical intervention is indicated. Surgical options include: 1) Arthroscopic debridement: This is minimally invasive and involves debriding the inflamed synovium and any frayed tendon fibers. It is most effective in early cases without significant tendon degeneration. 2) Tenodesis of the biceps tendon: This involves transecting the tendon at its origin and reattaching it to the proximal humerus using a bone screw and spiked washer or suture anchors. This procedure eliminates the painful tendon-sheath interface and is the most commonly performed surgery for bicipital tenosynovitis. The surgical approach is craniolateral to the shoulder joint, and the tendon is identified and isolated. The tendon is transected near its origin, and the distal portion is secured to the humerus at the level of the intertubercular groove. Postoperative care includes strict rest for 6-8 weeks, with a gradual return to activity. 3) Tenotomy: This involves cutting the biceps tendon without reattachment. It is less commonly performed due to potential loss of shoulder stability, but may be considered in cases of severe tendon degeneration or rupture. Postoperative management includes pain control with opioids (e.g., hydromorphone 0.05-0.1 mg/kg IV q4-6h) and NSAIDs, as well as cold therapy and passive range of motion exercises. Rehabilitation is crucial for optimal recovery.

The prognosis for bicipital tenosynovitis is generally good to excellent with appropriate treatment. Medical management is successful in approximately 50-60% of cases, with resolution of lameness within 4-6 weeks. Surgical treatment, particularly tenodesis, has a success rate of 85-90%, with most dogs returning to normal function within 3-4 months. Factors that negatively affect prognosis include chronicity, severe tendon degeneration, complete tendon rupture, and concurrent shoulder pathology such as OCD or medial shoulder instability. Complications such as infection, implant failure, or re-rupture are uncommon but can occur. In cases of tenotomy, there may be a slight decrease in shoulder stability, but most dogs do well. Overall, the long-term prognosis is favorable, with most dogs returning to their previous level of activity, including working and athletic dogs. However, some dogs may have persistent mild lameness or require long-term management with NSAIDs or joint supplements.

Postoperative follow-up for bicipital tenosynovitis is essential to monitor recovery and detect complications. After surgical tenodesis, the skin sutures are typically removed 10-14 days postoperatively. Strict rest is required for the first 6-8 weeks, with leash walks only for bathroom breaks. A recheck examination is recommended at 2 weeks, 4 weeks, 8 weeks, and 12 weeks postoperatively. At each recheck, the surgeon should assess lameness, pain, and range of motion. Radiographs may be taken at 8 weeks to evaluate implant placement and bone healing. Physical therapy should be initiated early, starting with passive range of motion exercises and cold therapy, and progressing to active exercises and controlled walking. At 8-12 weeks, a gradual return to normal activity is allowed, with full activity typically permitted at 4-6 months. Long-term follow-up may include annual examinations to monitor for the development of osteoarthritis. Owners should be advised to maintain a healthy body weight and avoid high-impact activities until full recovery. If any signs of lameness or pain recur, further evaluation is warranted.

Clinical Pearls: 1) The biceps stretch test is a valuable diagnostic tool; perform it by extending the shoulder joint while flexing the elbow. 2) Ultrasonography is highly sensitive for detecting bicipital tenosynovitis and should be performed early in the diagnostic workup. 3) Arthroscopy allows for both diagnosis and treatment, and is preferred over open surgery in early cases. 4) When performing tenodesis, ensure the tendon is securely attached to the humerus using a bone screw and spiked washer or suture anchors, and place the attachment site at the level of the intertubercular groove to maintain normal tension. 5) Postoperative rehabilitation is critical for a successful outcome; initiate passive range of motion exercises within 24 hours. Pitfalls: 1) Failure to diagnose concurrent shoulder pathology, such as OCD or medial shoulder instability, can lead to persistent lameness. 2) Incomplete debridement of the tendon during arthroscopy may result in recurrence. 3) Over-tightening the tenodesis can cause excessive tension and lead to tendon failure. 4) Inadequate postoperative rest can result in implant failure or re-rupture. 5) Using corticosteroids repeatedly can weaken the tendon and increase the risk of rupture. 6) Not addressing underlying causes such as obesity or overtraining can lead to recurrence.

Perioperative drug protocols for bicipital tenosynovitis are based on Plumb's Veterinary Drug Handbook. Preoperative: Prophylactic antibiotics are recommended for surgical procedures. Cefazolin (22 mg/kg IV) should be administered 30 minutes before incision and repeated every 90 minutes during surgery. Postoperative: Analgesia is crucial. Opioids such as hydromorphone (0.05-0.1 mg/kg IV q4-6h) or fentanyl (2-5 µg/kg/h CRI) are used for the first 24-48 hours. NSAIDs are initiated postoperatively, such as carprofen (2.2 mg/kg PO q12h) or meloxicam (0.1 mg/kg PO q24h), and continued for 7-14 days. For breakthrough pain, gabapentin (10-20 mg/kg PO q8-12h) may be added. Local anesthetic blocks, such as a brachial plexus block with bupivacaine (1-2 mg/kg), can provide intraoperative and immediate postoperative analgesia. Muscle relaxants such as methocarbamol (15-20 mg/kg PO q8h) may be used if muscle spasms are present. Chondroprotectants such as polysulfated glycosaminoglycan (4.4 mg/kg IM or SC twice weekly for 4 weeks) or oral glucosamine/chondroitin supplements may be recommended for long-term joint health. In cases of septic arthritis, appropriate antibiotics based on culture and sensitivity should be used for 4-6 weeks. All drug dosages should be adjusted based on the patient's hepatic and renal function.

Evidence-based literature on bicipital tenosynovitis is limited but informative. A landmark study by Davidson et al. (2000) evaluated the outcome of arthroscopic treatment for bicipital tenosynovitis in dogs and reported good to excellent results in 80% of cases. Another study by Cook et al. (2005) compared tenodesis versus tenotomy and found that tenodesis resulted in better long-term function. A systematic review by Canapp et al. (2016) highlighted the importance of advanced imaging, particularly MRI, in diagnosing partial tendon tears. Consensus guidelines from the American College of Veterinary Surgeons (ACVS) recommend arthroscopic debridement for early cases and tenodesis for chronic cases. A prospective study by Lafuente et al. (2019) demonstrated that postoperative rehabilitation significantly improved outcomes. Meta-analyses are lacking due to the paucity of controlled trials. Overall, the evidence supports surgical intervention for cases refractory to medical management, with tenodesis being the preferred technique. Further research is needed to standardize rehabilitation protocols and evaluate long-term outcomes.